The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Safety and Efficacy of Statins in Asians
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism
Guengerich, F. P. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.1 · Cited by 1,267
Genetic contribution to variable human CYP3A-mediated metabolism
Lamba, J. K., Lin, Y. S., Schuetz, E. G., & Thummel, K. E. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00066-2 · Cited by 990
Tan, C.-E., Ma, S., Wai, D., Chew, S.-K., & Tai, E.-S. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1182 · Cited by 824
A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)
Hsiang, B., Zhu, Y., Wang, Z., Wu, Y., Sasseville, V., Yang, W.-P., & Kirchgessner, T. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37161 · Cited by 641
Molecular Basis of Ethnic Differences in Drug Disposition and Response
Xie, H.-G., Kim, R. B., Wood, A. J., & Stein, C. M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.815 · Cited by 600
Sever, P. S., Dahl??f, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2004) · Drugs · doi:10.2165/00003495-200464002-00005 · Cited by 524
Nishizato, Y. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00060-2 · Cited by 511
LEE, E., RYAN, S., BIRMINGHAM, B., ZALIKOWSKI, J., MARCH, R., AMBROSE, H., MOORE, R., LEE, C., CHEN, Y., & SCHNECK, D. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.06.013 · Cited by 480
Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-Glycoprotein
Kirn, R. B., Wandel, C., Leake, B., Cvetkovic, M., Fromm, M. F., Dempsey, P. J., Roden, M. M., Belas, F., Chaudhary, A. K., Roden, D. M., et al. (1999) · Pharmaceutical Research · doi:10.1023/a:1018877803319 · Cited by 454
Evidence for inverse effects of OATP-C (SLC21A6) *5 and *1b haplotypes on pravastatin kinetics
Mwinyi, J. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.12.016 · Cited by 293
Matsuzaki, M., Kita, T., Mabuchi, H., Matsuzawa, Y., Nakaya, N., Oikawa, S., Saito, Y., Sasaki, J., Shimamoto, K., Itakura, H., et al. (2002) · Circulation Journal · doi:10.1253/circj.66.1087 · Cited by 260
Kim, K., Johnson, J. A., & Derendorf, H. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004268128 · Cited by 220
The Contribution of P‐glycoprotein to Pharmacokinetic Drug‐Drug Interactions
Yu, D. K. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922012006 · Cited by 199
Pharmacogenetics and psychopharmacotherapy
Poolsup, Po, L. W., & Knight (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00281.x · Cited by 197
HMG‐CoA reductase inhibitors and P‐glycoprotein modulation
Bogman, K., Peyer, A., Török, M., Küsters, E., & Drewe, J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703920 · Cited by 194
Hata, Y., Mabuchi, H., Saito, Y., Itakura, H., Egusa, G., Ito, H., Teramoto, T., Tsushima, M., Tada, N., Oikawa, S., et al. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.1 · Cited by 188
Thomas, G. N., Ho, S.-Y., Janus, E. D., Lam, K. S. L., Hedley, A. J., & Lam, T. H. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.07.022 · Cited by 178
Influence of Race or Ethnicity on Pharmacokinetics of Drugs
Johnson, J. A. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9702168 · Cited by 142
Mabuchi, H., Kita, T., Matsuzaki, M., Matsuzawa, Y., Nakaya, N., Oikawa, S., Saito, Y., Sasaki, J., Shimamoto, K., Itakura, H., et al. (2002) · Circulation Journal · doi:10.1253/circj.66.1096 · Cited by 132
Martin, P. D., Dane, A. L., Nwose, O. M., Schneck, D. W., & Warwick, M. J. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002237987 · Cited by 93
Takeda, M., Noshiro, R., Onozato, M. L., Tojo, A., Hasannejad, H., Huang, X.-L., Narikawa, S., & Endou, H. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.017 · Cited by 89
Matsuzawa, Y., Kita, T., Mabuchi, H., Matsuzaki, M., Nakaya, N., Oikawa, S., Saitō, Y., Sasaki, J., Shimamoto, K., Itakura, H., et al. (2003) · Circulation Journal · doi:10.1253/circj.67.287 · Cited by 85
Wang, A., Yu, B., Luo, C., Tan, Z., Zhou, G., Wang, L., Zhang, W., Li, Z., Liu, J., & Zhou, H. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0848-7 · Cited by 80
Ito, H., Ouchi, Y., Ohashi, Y., Saito, Y., Ishikawa, T., Nakamura, H., & Orimo, H. (2001) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.8.33 · Cited by 73
The Kyushu Lipid Intervention Study Group (2000) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.7.110 · Cited by 67
Sasaki, J., & Arakawa, K. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)80166-5 · Cited by 66
Randomized Dose-Response Study of Rosuvastatin in Japanese Patients With Hypercholesterolemia
Saitō, Y., Goto, Y., Dane, A. L., Strutt, K., & Raza, A. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.329 · Cited by 53
The Prevalence of the Metabolic Syndrome in Korean Adults: Comparison of WHO and NCEP Criteria
Choi, S. H., Ahn, C. W., Cha, B. S., Chung, Y.-S., Lee, K. W., Lee, H. C., Huh, K. B., & Kim, D. J. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.2.198 · Cited by 48
Cc, W., Sy, R., Tanphaichitr, V., At, H., Suyono, S., & Yt, L. (2002) · PubMed · Cited by 46
51321例の日本人高コレステロール血症患者を対象とした最小副作用での6年間の低容量シンバスタチン療法における血清コレステロールの持続的低下 大規模全国コホート試験J-LIT試験の意義
Matsuzawa, Y., Kita, T., Mabuchi, H., Matsuzaki, M., Nakaya, N., Oikawa, S., SAITO, Y., Sasaki, J., & Itakura, H. (2003) · Circulation · Cited by 42
Saito, M., Hirata‐Koizumi, M., Urano, T., Miyake, S., & Hasegawa, R. (2005) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2004.00605.x · Cited by 37
Horiuchi, H., Kita, T., Mabuchi, H., Matsuzaki, M., Matsuzawa, Y., Nakaya, N., Oikawa, S., Saitō, Y., Sasaki, J., Shimamoto, K., et al. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52552.x · Cited by 27
Wang, K., & Ting, C.-T. (2001) · Japanese Heart Journal · doi:10.1536/jhj.42.725 · Cited by 25
Coronary heart disease risk in Japan ? an East/West divide?
KITA, T. (2004) · European Heart Journal Supplements · doi:10.1016/j.ehjsup.2004.01.003 · Cited by 24
Efficacy of Atorvastatin in Primary Hypercholesterolemia
(1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00092-1 · Cited by 24
Mabuchi, H., Nohara, A., Higashikata, T., Ueda, K., Bujo, H., Matsushima, T., Ikeda, Y., & Nii, M. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.152 · Cited by 23
STATT: a titrate-to-goal study of simvastatin in asian patients with coronary heart disease
Chung, N., Cho, S.-Y., Choi, D., Zhu, J.-R., Lee, K., Lee, P.-Y., Lee, S., Lee, S., Wang, J.-J., Yin, W., et al. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80074-6 · Cited by 23
Garmendia, F., Brown, A. S., Reiber, I., & Adams, P. C. (2000) · Current Medical Research and Opinion · doi:10.1185/030079900750176853 · Cited by 22
Sasaki, J., Arakawa, K., Iwashita, M., Matsushita, Y., Kono, S., & for the Kyushu Lipid InterventionStudy (KLIS) Group (2003) · Circulation Journal · doi:10.1253/circj.67.473 · Cited by 20
Yamamoto, A., Arakawa, K., Sasaki, J., Matsuzawa, Y., Takemura, K., Tsushima, M., Fujinami, T., Mabuchi, H., Itakura, H., Yamada, N., et al. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.48 · Cited by 19
Saitō, Y., Shirai, K., SASAKI, N., Shinomiya, M., & Yoshida, S. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.99 · Cited by 19
Koizumi, J., Shimizu, M., Miyamoto, S., Origasa, H., & Mabuchi, H. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.251 · Cited by 18
Chan, P., Huang, T., Tomlinson, B., Lee, C., & Lee, Y. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04327.x · Cited by 12
Tomlinson, B., Mak, T. W. L., Tsui, J. Y. Y., Woo, J., Shek, C. C., Critchley, J., & Masarei, J. R. L. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80036-0 · Cited by 11
Clinical efficacy of fluvastatin for hyperlipidemia in Japanese patients
Teramoto, T., Goto, Y., Kurokawa, K., Nakamura, H., Yoshida, S., Saito, Y., Nakaya, N., Itakura, H., Takaku, F., Yamada, N., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80013-x · Cited by 7
Yoshida, H., Yanai, H., Shoda, T., Furutani, N., Sato, N., & Tada, N. (2005) · Current Therapeutic Research · doi:10.1016/j.curtheres.2005.12.008 · Cited by 4
Ishikawa, T., Ito, H., Ouchi, Y., Ohashi, Y., Saitō, Y., Nakamura, H., Orimo, H., & PATE Investigators (2005) · Current Therapeutic Research · doi:10.1016/j.curtheres.2005.03.004 · Cited by 3
Cited by
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.003 · Cited by 2,691
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.002 · Cited by 1,751
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000624 · Cited by 907
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
Metadata
- Authors
- Liao, J. K.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 99
- Issue
- 3
- Pages
- 410-414
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2033024867
- Cited by
- 267
- References
- 49
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.